BioSpace News Archive

Proxima Clinical Research (“Proxima CRO”) is proud to join the hundreds of other companies from across the U.S. today in celebration of the Great Place to Work™ Certification Nation Day.

Infinity BiologiX, LLC (IBX), a leading next-generation central laboratory providing sample collection and processing, storage, analytical services, and scientific and technical support, has named Robin Grimwood as Chief Executive Officer.

Cardiac Insight, Inc. (“Cardiac Insight” or the “Company”) is a healthcare innovator specializing in wearable cardiac sensors and proprietary software that automatically analyzes electrocardiogram (ECG) data to improve early detection and diagnosis of cardiac arrythmias, such as atrial fibrillation (AFib).

The global atrial fibrillation market is expected to reach US$ 18,085.96 Mn in 2027 from US$ 6,446.08 Mn in 2019.

The report highlights the key factors driving the market growth and prominent players with their developments in the market.

The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

The report highlights trends prevailing in the market, and the factors driving and hindering the market growth.

Breckenridge Pharmaceutical, Inc. announces that it has signed a multi-product agreement with Aggrega Pharma, LLC. under which Aggrega will develop, manufacture and supply pharmaceutical products for marketing, sale and distribution by Breckenridge.

Enanta Pharmaceuticals, Inc. today announced positive data from the first two dose cohorts of its Phase 1b study of EDP-514 in viremic chronic HBV patients who were not being treated with a nucleoside reverse transcriptase inhibitor (NUC).

Cyteir Therapeutics, Inc. today announced the closing of its initial public offering of 7,400,000 shares of its common stock at an initial public offering price of $18.00 per share.